1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT,
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): MAY 29, 1997 (MAY 23, 1997)
NU-TECH BIO-MED, INC.
(Exact Name of Registrant as Specified in Charter)
DELAWARE 0-11772 25-1411971
(State or Other Jurisdiction (Commission File Number) (I.R.S. Employer
of Incorporation) Identification No.)
55 ACCESS ROAD
WARWICK, RHODE ISLAND 02886
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (401) 732-6520
2
INDEX TO CURRENT REPORT ON FORM 8-K
OF NU-TECH BIO-MED, INC.
MAY 29, 1997
ITEM PAGE
- ---- ----
ITEM 5. OTHER EVENTS 3
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS 3
SIGNATURES 4
-2-
3
ITEM 5. OTHER EVENTS.
On May 23, 1997, a complaint was filed against Nu-Tech Bio-Med, Inc.
(the "Company") and others in an action in the United States District Court for
the Southern District of New York captioned Mordechai Gurary v. Isaac Winehouse,
Isaac Winehouse d/b/a Wall & Broad Equities and Nu-Tech Bio-Med, Inc. (Docket
No. 97 Civ. 3803 (LBS)). As of the date of this report, service of the complaint
has not been effected upon the Company. The complaint alleges that the Company
and the other defendants violated Section 10(b) of the Securities Exchange Act
of 1934 (the "Exchange Act") and Section 349 of the General Business Law of the
State of New York (the "GBL"). The claims against the Company under the Exchange
Act and the GBL are purportedly based on allegations that the Company knew of
and failed to disclose, among other things, unlawful trading activity in the
Company's securities by the other defendants named in the action. The complaint
seeks compensatory damages in an unstated amount, seeks to enjoin the Company
from registering certain Series A Convertible Preferred Stock until the
determination of the action, and seeks reasonable attorneys' and expert fees as
well as treble and punitive damages.
The Company believes that the claims are without merit, and that it has
good defenses which it will assert at the appropriate time. The action is
currently in its preliminary stages.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
EXHIBIT NO. DOCUMENT
- ----------- --------
99 Summons and Complaint in the action "Mordechai Gurary v. Isaac Winehouse,
Isaac Winehouse d/b/a Wall & Broad Equities and Nu-Tech Bio-Med, Inc." Case
No. 97 Civ. 3803 (LBS) in the United States District Court, Southern District of
New York
-3-
4
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
NU-TECH BIO-MED, INC.
By: /s/ J. Marvin Feigenbaum
------------------------------
Name: J. Marvin Feigenbaum
Title: Chief Executive Officer
Date: May 29, 1997
-4-
5
EXHIBIT INDEX
EXHIBIT NO. DOCUMENT
- ----------- --------
99 Summons and Complaint in the action "Mordechai Gurary v. Isaac Winehouse,
Isaac Winehouse d/b/a Wall & Broad Equities and Nu-Tech Bio-Med, Inc." Case
No. 97 Civ. 3803 (LBS) in the United States District Court, Southern District of
New York